Cargando…
Mortality and incidence of second cancers following treatment for testicular cancer
We studied 5555 seminoma patients and 3733 patients with nonseminomatous testicular cancers diagnosed in Southeast England between 1960 and 2004. For both groups survival improved over time: 10-year relative survival increased from 78% in 1960–1969 to 99% in 1990–2004 for seminomas, and from 55 to 9...
Autores principales: | Robinson, D, Møller, H, Horwich, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360021/ https://www.ncbi.nlm.nih.gov/pubmed/17262080 http://dx.doi.org/10.1038/sj.bjc.6603589 |
Ejemplares similares
-
Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
por: Horwich, A, et al.
Publicado: (2014) -
Serum cholesterol and testicular cancer incidence in 45 000 men followed for 25 years
por: Wiréhn, A-B, et al.
Publicado: (2005) -
Second primary cancers in patients with squamous cell carcinoma of the skin
por: Maitra, S K, et al.
Publicado: (2005) -
Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study
por: Royle, J A, et al.
Publicado: (2011) -
Increased pancreatic cancer risk following radiotherapy for testicular cancer
por: Hauptmann, Michael, et al.
Publicado: (2016)